Baudax Bio Inc.

NASDAQ: BXRX · Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM

Baudax Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
1.27M 1.08M
Cost of Revenue
7.01M 2.44M
Gross Profit
-5.74M -1.36M
Operating Income
-35.74M -19.01M
Interest Income
n/a n/a
Pretax Income
-58.8M -19.77M
Net Income
-58.8M -19.77M
Selling & General & Admin
24.12M 45.31M
Research & Development
5.88M 3.13M
Other Expenses
n/a 2.58M
Operating Expenses
30M 51.01M
Interest Expense
21.07M 2.3M
Selling & Marketing Expenses
9.41M n/a
Cost & Expenses
37.01M 53.46M
Income Tax Expense
n/a 3.84M
Shares Outstanding (Basic)
331.62K 54.74K
Shares Outstanding (Diluted)
331.62K 54.74K
EPS (Basic)
-177.3 -361.16
EPS (Diluted)
-177.3 -361.16
EBITDA
-35.58M -48.26M
EBIT
-37.73M -50.84M
Depreciation & Amortization
2.16M -29.25M